blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1633384

EP1633384 - STABLE ANALOGS OF GLP-1 [Right-click to bookmark this link]
Former [2006/11]STABLE ANALOGS OF PEPTIDE AND POLYPEPTIDE THERAPEUTICS
[2011/40]
StatusNo opposition filed within time limit
Status updated on  18.01.2013
Database last updated on 21.12.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
TRUSTEES OF TUFTS COLLEGE
Ballou Hall
Medford, MA 02155 / US
[2006/11]
Inventor(s)01 / BACHOVCHIN, William, W.
75 Cambridge Parkway, Apt E609
Cambridge, MA 02142 / US
02 / LAI, Hung-Sen
11 Seten Circle
Andover, MA 01810 / US
03 / SANFORD, David, George
52 Hopkins Street
Reading, MA 01867 / US
 [2007/40]
Former [2006/11]01 / BACHOVCHIN, William, W.
7 Warwick Street
Melrose, MA 02176 / US
02 / LAI, Hung-Sen
7 Conant Road U-70
Winchester, MA 01890 / US
03 / SANFORD, David, George
52 Hopkins Street
Reading, MA 01867 / US
Representative(s)Horner, Martin Grenville, et al
Marks & Clerk LLP
Aurora
120 Bothwell Street
Glasgow
G2 7JS / GB
[N/P]
Former [2012/11]Horner, Martin Grenville, et al
Marks & Clerk LLP Aurora 120 Bothwell Street Glasgow
G2 7JS / GB
Former [2008/33]Horner, Martin Grenville, et al
Marks & Clerk Scotland 19 Royal Exchange Square
Glasgow G1 3AE / GB
Former [2006/11]Horner, Martin Grenville, et al
Marks & Clerk, 19 Royal Exchange Square
Glasgow G1 3AE / GB
Application number, filing date04752496.217.05.2004
[2006/11]
WO2004US15488
Priority number, dateUS20030471411P15.05.2003         Original published format: US 471411 P
[2006/11]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004103390
Date:02.12.2004
Language:EN
[2004/49]
Type: A2 Application without search report 
No.:EP1633384
Date:15.03.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 02.12.2004 takes the place of the publication of the European patent application.
[2006/11]
Type: B1 Patent specification 
No.:EP1633384
Date:14.03.2012
Language:EN
[2012/11]
Search report(s)International search report - published on:EP30.06.2005
ClassificationIPC:A61K38/04, A61K38/26
[2011/40]
CPC:
C07K14/575 (EP,US); A23K20/168 (US); A23K20/184 (EP,US);
A61K38/1709 (EP,US); A61K38/177 (EP,US); A61K38/22 (EP,US);
A61K38/26 (EP,US); A61P1/00 (EP); A61P1/04 (EP);
A61P11/16 (EP); A61P19/10 (EP); A61P25/00 (EP);
A61P25/18 (EP); A61P25/24 (EP); A61P25/28 (EP);
A61P3/04 (EP); A61P3/06 (EP); A61P3/10 (EP);
A61P9/00 (EP); A61P9/04 (EP); A61P9/10 (EP);
A61P9/12 (EP); C07K14/47 (US); C07K14/57545 (EP,US);
C07K14/57563 (EP,US); C07K14/60 (EP,US); C07K14/605 (EP,US);
C07K14/765 (US); C07K7/08 (US); A61K38/00 (EP,US);
A61K39/00 (EP,US); C07K14/005 (US) (-)
Former IPC [2006/11]A61K38/04
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/11]
TitleGerman:STABILE ANALOGA VON GLP-1[2011/40]
English:STABLE ANALOGS OF GLP-1[2011/40]
French:ANALOGUES STABLES DE GLP-1[2011/40]
Former [2006/11]STABILE ANALOGA VON PEPTID- UND POLYPEPTID-THERAPEUTIKA
Former [2006/11]STABLE ANALOGS OF PEPTIDE AND POLYPEPTIDE THERAPEUTICS
Former [2006/11]AGENTS THERAPEUTIQUES COMPRENANT DES ANALOGUES STABLES DE PEPTIDES ET DE POLYPEPTIDES
Entry into regional phase08.12.2005National basic fee paid 
08.12.2005Designation fee(s) paid 
08.12.2005Examination fee paid 
Examination procedure08.12.2005Examination requested  [2006/11]
07.03.2006Amendment by applicant (claims and/or description)
09.12.2008Despatch of a communication from the examining division (Time limit: M06)
19.06.2009Reply to a communication from the examining division
03.02.2010Despatch of a communication from the examining division (Time limit: M06)
13.08.2010Reply to a communication from the examining division
10.10.2011Communication of intention to grant the patent
30.01.2012Fee for grant paid
30.01.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  09.12.2008
Opposition(s)17.12.2012No opposition filed within time limit [2013/08]
Fees paidRenewal fee
30.05.2006Renewal fee patent year 03
30.05.2007Renewal fee patent year 04
28.05.2008Renewal fee patent year 05
12.05.2009Renewal fee patent year 06
31.03.2010Renewal fee patent year 07
11.05.2011Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU17.05.2004
AT14.03.2012
BE14.03.2012
CY14.03.2012
CZ14.03.2012
DK14.03.2012
EE14.03.2012
FI14.03.2012
NL14.03.2012
PL14.03.2012
RO14.03.2012
SI14.03.2012
SK14.03.2012
TR14.03.2012
LU17.05.2012
MC31.05.2012
BG14.06.2012
GR15.06.2012
PT16.07.2012
[2014/34]
Former [2014/27]AT14.03.2012
BE14.03.2012
CY14.03.2012
CZ14.03.2012
DK14.03.2012
EE14.03.2012
FI14.03.2012
NL14.03.2012
PL14.03.2012
RO14.03.2012
SI14.03.2012
SK14.03.2012
TR14.03.2012
LU17.05.2012
MC31.05.2012
BG14.06.2012
GR15.06.2012
PT16.07.2012
Former [2014/21]AT14.03.2012
BE14.03.2012
CY14.03.2012
CZ14.03.2012
DK14.03.2012
EE14.03.2012
FI14.03.2012
NL14.03.2012
PL14.03.2012
RO14.03.2012
SI14.03.2012
SK14.03.2012
TR14.03.2012
MC31.05.2012
BG14.06.2012
GR15.06.2012
PT16.07.2012
Former [2013/33]AT14.03.2012
BE14.03.2012
CY14.03.2012
CZ14.03.2012
DK14.03.2012
EE14.03.2012
FI14.03.2012
NL14.03.2012
PL14.03.2012
RO14.03.2012
SI14.03.2012
SK14.03.2012
MC31.05.2012
BG14.06.2012
GR15.06.2012
PT16.07.2012
Former [2013/08]AT14.03.2012
BE14.03.2012
CY14.03.2012
CZ14.03.2012
DK14.03.2012
EE14.03.2012
FI14.03.2012
NL14.03.2012
PL14.03.2012
RO14.03.2012
SI14.03.2012
SK14.03.2012
MC31.05.2012
GR15.06.2012
PT16.07.2012
Former [2013/07]AT14.03.2012
BE14.03.2012
CY14.03.2012
CZ14.03.2012
EE14.03.2012
FI14.03.2012
PL14.03.2012
RO14.03.2012
SI14.03.2012
SK14.03.2012
MC31.05.2012
GR15.06.2012
PT16.07.2012
Former [2013/03]BE14.03.2012
CY14.03.2012
CZ14.03.2012
EE14.03.2012
FI14.03.2012
PL14.03.2012
RO14.03.2012
SI14.03.2012
SK14.03.2012
MC31.05.2012
GR15.06.2012
PT16.07.2012
Former [2013/01]BE14.03.2012
CY14.03.2012
CZ14.03.2012
EE14.03.2012
FI14.03.2012
PL14.03.2012
RO14.03.2012
SI14.03.2012
SK14.03.2012
GR15.06.2012
PT16.07.2012
Former [2012/50]BE14.03.2012
CY14.03.2012
CZ14.03.2012
EE14.03.2012
FI14.03.2012
PL14.03.2012
RO14.03.2012
SI14.03.2012
SK14.03.2012
GR15.06.2012
Former [2012/49]BE14.03.2012
CY14.03.2012
CZ14.03.2012
EE14.03.2012
FI14.03.2012
PL14.03.2012
RO14.03.2012
SI14.03.2012
GR15.06.2012
Former [2012/48]BE14.03.2012
CY14.03.2012
EE14.03.2012
FI14.03.2012
GR15.06.2012
Former [2012/46]BE14.03.2012
CY14.03.2012
FI14.03.2012
GR15.06.2012
Former [2012/41]CY14.03.2012
FI14.03.2012
GR15.06.2012
Former [2012/37]FI14.03.2012
GR15.06.2012
Former [2012/36]GR15.06.2012
Cited inInternational search[A]US5276137  (OJIMA IWAO [US], et al);
 [A]US6184201  (DRUCKER DANIEL J [CA], et al);
by applicantUS3773919
 US4767628
 US5026685
 WO9318797
 US5328899
 WO9415587
 US5545618
 US6075009
 US6410701
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.